References

1. Amaral, F., Miranda-Vilela, A., Lordelo, G., Ribeiro, I., Daldegan, M., & Grisolia, C. (2017). Interactions among methylenetetrahydrofolate reductase (MTHFR) and cystathionine β-synthase (CBS) polymorphisms - a cross-sectional study: multiple heterozygosis as a risk factor for higher homocysteine levels and vaso-occlusive episodes. Genetics and Molecular Research, 16(1).

2. Anderson, S., Panka, J., Rakobitsch, R., Tyre, K., & Pulliam, K. (2016). Anxiety and Methylenetetrahydrofolate Reductase Mutation Treated With S-Adenosyl Methionine and Methylated B Vitamins. Integrative Medicine: A Clinician’s Journal, 15(2), 48–52.

3. Di Renzo, L., Marsella, L. T., Sarlo, F., Soldati, L., Gratteri, S., Abenavoli, L., & De Lorenzo, A. (2014). C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention. Journal of Translational Medicine, 12, 329.

4. Ferlazzo, N., Currò, M., Zinellu, A., Caccamo, D., Isola, G., Ventura, V., … Ientile, R. (2017). Influence of MTHFR Genetic Background on p16 and MGMT Methylation in Oral Squamous Cell Cancer. International Journal of Molecular Sciences, 18(4), 724.

5. Genetics Home Reference (2017). MTHFR gene. Genetics Home Reference. Retrieved from https://ghr.nlm.nih.gov/gene/MTHFR

6. Handy, D. E., Castro, R., & Loscalzo, J. (2011). Epigenetic Modifications: Basic Mechanisms and Role in Cardiovascular Disease. Circulation, 123(19), 2145-2156. doi:10.1161/circulationaha.110.956839

7. Knowles, L., Morris, A. A. M., & Walter, J. H. (2016). Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency. JIMD Reports, 29, 103–107.

8. Mead, M. N. (2007). Nutrigenomics: The Genome–Food Interface. Environmental Health Perspectives, 115(12). doi:10.1289/ehp.115-a582

9. MTHFR gene variant. (n.d.). Retrieved November 28, 2017, from https://rarediseases.info.nih.gov/diseases/10953/mthfr-gene-mutation

10. Smith, S. B., Reenilä, I., Männistö, P. T., Slade, G. D., Maixner, W., Diatchenko, L., & Nackley, A. G. (2014). Epistasis Between Polymorphisms in COMT, ESR1, and GCH1 Influences COMT Enzyme Activity and Pain. Pain, 155(11), 2390–2399.

11. Trimmer, E. E. (2013). Methylenetetrahydrofolate Reductase: Biochemical Characterization and Medical Significance. Current Pharmaceutical Design, 19(14), 2574-2593. doi:10.2174/1381612811319140008

12. Wu, J., Zhai, J., & Yang, J. (2016). Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk. Genetics And Molecular Research, 15(4).

13.Zappacosta, B., Mastroiacovo, P., Persichilli, S., Pounis, G., Ruggeri, S., Minucci, A., Iacoviello, L. (2013). Homocysteine Lowering by Folate-Rich Diet or Pharmacological Supplementations in Subjects with Moderate Hyperhomocysteinemia. Nutrients, 5(5), 1531–1543.